Comparison of Two Hydroxy-apatite Coated Hip Stems

NCT ID: NCT03577522

Last Updated: 2025-12-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

56 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-07-19

Study Completion Date

2024-01-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In this study, the investigators propose to randomize 80 subjects to receive either the Avenir cementless hip stem or a competing, HA-coated hip stem (Corail, DePuy-Synthes) and follow these patients for a period of 2 years post-surgery. The investigators aim to determine if the Avenir cementless hip stem has equivalent or better fixation and clinical outcomes compared to a predicate hip stem with longer clinical history.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a multi-center, randomized controlled trial of patients undergoing primary total hip arthroplasty. This study will be focused on enrollment at a single site with possible expansion to additional centers should patient enrollment occur at a slower than expected rate. Decision to expand the study to additional centers will be mutually agreed upon by both the clinical site and the study sponsor.

Patients will be randomized to two study groups:

1. Zimmer Avenir cementless, HA-coated femoral hip stem with matching Trilogy IT cup;
2. DePuy-Synthes Corail cementless, HA-coated, non-collared femoral hip stem with matching Pinnacle cup Patient allocation to the study groups will occur following a randomized 4-block design.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hip Osteoarthritis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Avenir cementless hip stem

Total hip arthroplasty: Avenir vs Corail

Group Type ACTIVE_COMPARATOR

Avenir cementless hip stem

Intervention Type DEVICE

Avenir cementless hip stem vs Corail HA-coated hip stem

Corail HA-coated hip stem

Total hip arthroplasty: Corail vs Avenir

Group Type ACTIVE_COMPARATOR

Corail HA-coated hip stem

Intervention Type DEVICE

Avenir cementless hip stem vs Corail HA-coated hip stem

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Avenir cementless hip stem

Avenir cementless hip stem vs Corail HA-coated hip stem

Intervention Type DEVICE

Corail HA-coated hip stem

Avenir cementless hip stem vs Corail HA-coated hip stem

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Symptomatic osteoarthritis of the hip undergoing primary total hip arthroplasty
* Between the ages of 18 and 79 inclusive
* Patients willing and able to comply with follow-up requirements and self-evaluations
* Ability to give informed consent

Exclusion Criteria

* Requires specialty implant (e.g., suspected metal allergy, coxa vera implant)
* Avascular necrosis
* Unresolved infection of the hip
* Hip fracture
* Hip dysplasia
* At risk for loss to follow-up
* Prior surgery to the ipsilateral hip
* Severe proximal femoral deformity preventing the use of standard proximal press-fit femoral components
* Medical condition precluding major surgery
* Current or pending patient incarceration
Minimum Eligible Age

18 Years

Maximum Eligible Age

79 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Canadian Radiostereometric Analysis Network

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Thomas Turgeon, MD

Role: PRINCIPAL_INVESTIGATOR

Concordia Joint Replacement Group

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Concordia Hospital

Winnipeg, Manitoba, Canada

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Canada

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

B2018-031

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Avenir Complete Post-Market Clinical Follow-Up Study
NCT04731077 ACTIVE_NOT_RECRUITING NA